FTPR08

Nom de l'organisation

Labomar S.p.A.

SRN

IT-MF-000007965

Statut du fabricant

Actif

Santé des certificats sur le portefeuille de ce fabricant.

5 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW999

  Before administering to children under three years of age, it is recommended that you seek the advice of your doctor. In children under three years of age, if symptoms persist and worsen after first two days of treatment, consult your doctor. If you do not notice appreciable results after a short period of treatment (7 days), contact your doctor, in any case do not use for more than 15 days. Close the bottle carefully after use. Do not take it if you are allergic, intolerant or hypersensitive to any component. Do not use for purposes other than that for which the product is intended. No side effects associated by used the device have been observed. If you notice the appearance of side effects, inform your doctor. Expiry date refers to the product in its intact packaging and properly stored. In the event of concomitant pharmacological treatment, although no interactions with drugs are known, it is advisable to consult a doctor before use. Do not exceed the recommended daily dose. Any serious incident that has occurred in relation to the device should be reported to the manufacturer and the Competent Authority. In case of any undesired event always seek medical advice. Wash carefully the measuring cup after use. Close the bottle carefully after use The period of validity after the first opening of the syrup is 2 months.
• CW010

  EUDAMED n'a pas publié de description pour ce code.
• CW007

  EUDAMED n'a pas publié de description pour ce code.
• CW032

  EUDAMED n'a pas publié de description pour ce code.
• CW135

  EUDAMED n'a pas publié de description pour ce code.

Marché principal en Italie ; disponible dans 1 pays au total.

Dénomination commerciale

non renseigné

Code d'UDI-DI

08056300621232

Basic UDI-DI

805630062FTPR089G

Numéro de référence/catalogue

FTPR08

Entité d'attribution

GS1

Catégorie de risque

Classe IIa

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Dicotuss baby med is a medical device composed of substances, not sterile, intended for short term invasive contact with respect to body orifices (oral cavity), designed for the treatment of productive and dry cough in children (1+). Its specific formula creates a mucoadhesive protective film with a barrier effect in the throat. In case of dry cough, Baby Cough syrup calms the cough by protecting the mucosa from irritating agents. In the case of a productive cough, it promotes the hydration of the mucus and facilitates its physiological expectoration. The product can be used as adjuvant for the treatment of dry and productive cough.

URL des informations complémentaires

https://labomar.com/products/ftpr-08/

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES